Medicines
Sacituzumab govitecan cost and availability in India
Sacituzumab govitecan is a newer, patented medicine with a high cost that depends on body weight, two doses in every cycle and how long treatment continues. Availability in India has been limited. This page explains what makes up the total, how to get a clear estimate, and which sources of support may be worth exploring.
On this page
- What shapes the cost of sacituzumab govitecan in India, and is it available?
- The parts that make up the total
- What to ask before you start
- The vocabulary, in plain language
- Honest points about cost and value
- Getting the medicine in India
- Sources of financial support to explore
- What people assume about cost
- Common questions about cost and availability
The short answer
What shapes the cost of sacituzumab govitecan in India, and is it available?
Sacituzumab govitecan is a newer, patented antibody-drug conjugate, and it is among the more expensive breast cancer medicines. This page does not give prices, because they change, differ between sources and are often quoted in ways that confuse. Instead it explains what drives the total. The dose is worked out from your body weight, so a heavier person needs more vials. It is given twice in every three-week cycle, on day one and day eight, which means many doses over months. There is no fixed number of cycles, so the total depends on how long the treatment keeps working. On top of the drug itself come the day care charges for each infusion, anti-sickness medicines, blood tests before every dose, regular scans, growth factor injections if counts drop, and any hospital stays for side effects. Availability in India has been limited and has changed over time. Where it is not readily available, some patients have obtained it through special import permissions, which involve paperwork, waiting time and uncertainty. No generic or biosimilar version is approved, so be wary of unverified sources. Insurance cover, government schemes, employer policies and manufacturer patient assistance programmes vary widely. Before starting, it is sensible to ask your oncologist and the hospital's billing or financial counselling desk for a written estimate covering the drug, supportive care and tests.
Weight-based dosing
The amount of drug, and so the cost, rises with body weight.
Many doses over time
Two doses per cycle, continued while it works, add up quickly.
Ask for a written estimate
Include supportive medicines, tests and scans, not just the drug.
This page gives general information only. It does not quote prices or offer financing.What adds up
The parts that make up the total
The medicine is the largest part, but it is not the only one.
The medicine
Priced per vial. The number of vials per dose depends on your weight and on any dose reductions.
Infusion day charges
Day care bed, nursing, drip equipment and premedicines are charged for every dose.
That means two visits in each cycle.Tests and scans
Blood counts before each dose, liver and kidney tests, and scans every few months.
Supportive care
Medicines and care for side effects can add a meaningful amount.
May include
- Growth factor injections
- Anti-sickness and anti-diarrhoea medicines
- Hospital care for infection or dehydration
Questions to ask
What to ask before you start
Words you will hear
The vocabulary, in plain language
- Vial
- A small glass container of powdered medicine, mixed into the drip before use.
- Weight-based dose
- A dose calculated from your body weight in kilograms.
- Patented medicine
- A medicine that only the original company can sell for a period of time.
- Biosimilar
- A close copy of a biological medicine approved after the patent ends. None is approved for this drug.
- Patient assistance programme
- A scheme run by a manufacturer or charity to help eligible patients with access.
- Pre-authorisation
- Approval from an insurer before treatment starts.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Being straight with you
Honest points about cost and value
Cost is a real part of treatment decisions, and it is reasonable to talk about it openly with your oncologist.
The benefit is meaningful but limited
In pre-treated metastatic triple negative cancer it helped people live longer than chemotherapy, often by some months. It is not a treatment that makes cancer go away.
Other options exist
If this medicine is out of reach, other chemotherapy and, where relevant, other targeted treatments may still help.
Estimates can change
Dose changes, side effects and treatment length all move the final total.
What this page cannot tell you
It cannot tell you the current price or whether you qualify for any scheme. Ask the hospital's financial counsellor.
Availability
Getting the medicine in India
Access to newer cancer medicines in India can be uneven, and this one is no exception.
Local availability varies
Whether it can be sourced through regular channels depends on current approvals and supply. Your oncologist will know the present position.
Import routes
Where it is not readily available, special permission to import a medicine for an individual patient may be possible. This needs a prescription, documents and time.
Be careful with unverified sellers
Medicines offered online at unusually low prices, or without a proper bill and cold-chain storage, may be fake or damaged. Only use medicine your treating team has checked.
Clinical trials
Occasionally, trials of this or similar medicines are open in India, providing treatment as part of the study.
Financial help
Sources of financial support to explore
No single scheme covers everyone, but several routes are worth checking early.
Health insurance
Read your policy for day care cover, limits on newer medicines and sub-limits for cancer care. Start pre-authorisation before the first dose.
Government and employer schemes
Central and state schemes and employer policies each have their own rules on which medicines they include.
Charities and assistance programmes
Cancer charities and manufacturer programmes sometimes help, subject to eligibility. The hospital social worker can guide you.
Commonly believed
What people assume about cost
Online figures often show one vial, not a full dose, cycle or course.
No generic or biosimilar is approved. Unverified products may be unsafe.
The right choice depends on your cancer type, earlier treatment and health.
Some policies do. Check your policy wording and ask for pre-authorisation.
Questions we are asked
Common questions about cost and availability
Why does this page not give a price?
Prices change, differ between suppliers and depend on body weight, dose changes and how long treatment lasts. A single figure is likely to mislead. The hospital billing or financial counselling desk can give you a written estimate based on your own weight, planned schedule and the supportive care you are likely to need.
Why does my weight change the cost?
The dose is calculated from body weight, so a heavier person needs more medicine at each infusion. Because the drug comes in fixed-size vials, a small change in weight can sometimes mean an extra vial. If your weight changes a lot during treatment, the dose is usually recalculated.
Is there a generic version in India?
No generic or biosimilar version of sacituzumab govitecan is approved. Be very cautious about products described as cheaper copies, especially those sold online. Fake or badly stored cancer medicines can be ineffective or harmful. Your treating team should check any medicine before it is given.
Does insurance cover it?
It depends on your policy. Some cover day care chemotherapy and newer medicines within the sum insured, while others have exclusions or sub-limits. Ask your insurer for written confirmation and start pre-authorisation early, with your oncologist's prescription and treatment plan attached.
Is there any financial assistance?
Possible routes include manufacturer patient assistance programmes, cancer charities, government and employer schemes. Eligibility rules vary, and paperwork takes time. The hospital social worker or financial counsellor can help you understand which routes may apply to you.
What if we cannot afford it?
Tell your oncologist honestly. Other chemotherapy drugs and, depending on test results, other targeted treatments can still control metastatic breast cancer for a time. Choosing an option your family can sustain is a responsible decision, and your care will continue whatever you choose.
Can lowering the dose reduce the cost?
Doses are lowered only for medical reasons, such as severe side effects, not to save money, because a lower dose may work less well. If a reduction is medically needed, fewer vials may be used, but cost should not be the reason for changing the dose.
Are there hidden costs to plan for?
Families often forget travel, accommodation near the hospital, lost earnings, home help, food supplements and hospital stays for side effects. Listing these alongside the medical estimate gives a more realistic picture and helps you plan support from family or schemes.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Sources
- National Cancer Institute — Managing the cost of cancer care
- European Medicines Agency — Trodelvy product information
- American Society of Clinical Oncology — Financial considerations of cancer care
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.